Determining Value in Health Technology Assessment: Stay the Course or Tack Away? J. Jaime CaroJohn E. BrazierMichael Schlander Current Opinion Open access 09 November 2018 Pages: 293 - 299
Economic Burden of Renal Cell Carcinoma—Part I: An Updated Review Chun-Ru ChienDaniel M. GeynismanYa-Chen Tina Shih Review Article 23 November 2018 Pages: 301 - 331
Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Paul TappendenEmma SimpsonNick Morley Review Article 24 September 2018 Pages: 333 - 343
Cladribine Tablets for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Tosin LambeRui DuarteIan Pomeroy Review Article Open access 16 October 2018 Pages: 345 - 357
Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review Gian Luca Di TannaAnna BychenkovaGary Globe Systematic Review Open access 31 December 2018 Pages: 359 - 389
Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States Holly GuyLydia WalderMark Fisher Original Research Article Open access 27 November 2018 Pages: 391 - 405
Measuring Public Preferences for Health Outcomes and Expenditures in a Context of Healthcare Resource Re-Allocation Nicolas KrucienNathalie Pelletier-FleuryAmiram Gafni Original Research Article 30 November 2018 Pages: 407 - 417
Opioid Use is Associated with Higher Severity-Adjusted Episode Costs in Patients with Conservatively Managed Degenerative Joint Disease of the Back and Neck Brent A. MetfesselMichelle D. MentelSamuel Ho Original Research Article 06 December 2018 Pages: 419 - 433
Cost Effectiveness of Inhaled Mannitol (Bronchitol®) in Patients with Cystic Fibrosis Emma WarrenKristen MorganJoanna Leadbetter Original Research Article 22 January 2019 Pages: 435 - 446
